Results 51 to 60 of about 1,025,722 (378)
Background: Findings of reward disturbances in unaffected relatives of patients with schizophrenia suggest reward disturbances as an endophenotype for schizophrenia.
Mette Ødegaard Nielsen+8 more
doaj +1 more source
Schizophrenia in older adults [PDF]
Although the number of persons over the age of 55 with schizophrenia is expected to double over the next 20 years, the research data on older people with schizophrenia is limited.
American Psychiatric Association+12 more
core +2 more sources
Unseen Affective Faces Influence Person Perception Judgments in Schizophrenia. [PDF]
To demonstrate the influence of unconscious affective processing on consciously processed information among people with and without schizophrenia, we used a continuous flash suppression (CFS) paradigm to examine whether early and rapid processing of ...
Barrett, Lisa Feldman+2 more
core +1 more source
We have reported that a subpopulation of patients with schizophrenia have lower levels of vitamin B6 (VB6) in peripheral blood than do healthy controls. In a previous study, we found that VB6 level was inversely proportional to the patient’s positive and
Kazuya Toriumi+10 more
doaj +1 more source
Schizophrenia, social practices and cultural values: A conceptual introduction [PDF]
Schizophrenia is usually described as a fragmentation of subjective experience and the impossibility to engage in meaningful cultural and intersubjective practices. Although the term schizophrenia is less than 100 years old, madness is generally believed
Gonçalves, J.+2 more
core +1 more source
Subanesthetic ketamine treatment promotes abnormal interactions between neural subsystems and alters the properties of functional brain networks [PDF]
Acute treatment with subanesthetic ketamine, a non-competitive N-methyl-D-aspartic acid (NMDA) receptor antagonist, is widely utilized as a translational model for schizophrenia. However, how acute NMDA receptor blockade impacts on brain functioning at a
A Bifone+77 more
core +1 more source
Pdxdc1 modulates prepulse inhibition of acoustic startle in the mouse. [PDF]
Current antipsychotic medications used to treat schizophrenia all target the dopamine D2 receptor. Although these drugs have serious side effects and limited efficacy, no novel molecular targets for schizophrenia treatment have been successfully ...
Boutros, PC+5 more
core +1 more source
Gross Domestic Product (GDP) and productivity of schizophrenia trials: an ecological study [PDF]
The 5000 randomised controlled trials (RCTs) in the Cochrane Schizophrenia Group's database affords an opportunity to research for variables related to the differences between nations of their output of schizophrenia trials.
B Thornley+11 more
core +3 more sources
This article provides detailed information about schizophrenia. In particular, the following article provides detailed information on the causes of schizophrenia, diagnosis methods, and treatment measures for this disease.
openaire +3 more sources
Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far? [PDF]
In light of the number of studies conducted to examine the treatment of cognitive impairment associated with schizophrenia (CIAS), we critically reviewed recent CIAS trials.
Buchanan, Robert W+6 more
core